Vir Biotechnology (VIR) Research & Development (2018 - 2025)
Vir Biotechnology (VIR) has disclosed Research & Development for 8 consecutive years, with $88.3 million as the latest value for Q4 2025.
- Quarterly Research & Development fell 16.72% to $88.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $456.0 million through Dec 2025, down 9.98% year-over-year, with the annual reading at $456.0 million for FY2025, 9.98% down from the prior year.
- Research & Development hit $88.3 million in Q4 2025 for Vir Biotechnology, down from $151.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $195.2 million in Q3 2024 to a low of $86.1 million in Q2 2021.
- Historically, Research & Development has averaged $123.2 million across 5 years, with a median of $114.6 million in 2022.
- Biggest five-year swings in Research & Development: soared 107.56% in 2021 and later plummeted 37.46% in 2024.
- Year by year, Research & Development stood at $128.3 million in 2021, then increased by 20.91% to $155.2 million in 2022, then decreased by 29.78% to $109.0 million in 2023, then decreased by 2.65% to $106.1 million in 2024, then fell by 16.72% to $88.3 million in 2025.
- Business Quant data shows Research & Development for VIR at $88.3 million in Q4 2025, $151.5 million in Q3 2025, and $97.5 million in Q2 2025.